Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada

PURPOSE: High‐strength opioid formulations were delisted (removed) from Ontario's public drug formulary in January 2017, except for palliative patients. We evaluated the impact of this policy on opioid utilization and dosing. METHODS: We conducted a longitudinal study among patients receiving p...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Pharmacoepidemiol Drug Saf
Huvudupphovsmän: Martins, Diana, Khuu, Wayne, Tadrous, Mina, Juurlink, David N., Mamdani, Muhammad M., Paterson, J. Michael, Gomes, Tara
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2019
Ämnen:
Original Reports
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6518867/
https://ncbi.nlm.nih.gov/pubmed/30873707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.4764
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk